Low-dose cholecalciferol
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Low-dose cholecalciferol, covering 2022-12-09 to 2022-12-09. Get the full timeline:
Most recent: Clinical Trial Update: Repeated-dose Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of CTAP101, Immediate-release Calcifediol, High-dose Cholecalciferol, and Paricalcitol Plus Low-dose Cholecalciferol in Patients With Secondary Hyperparathyroidism, Chronic Kidney Disease 3-4 and Vitamin D Insufficiency [Phase 4]